Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TaiMed Biologics Inc. (4147) Income Statement

TaiMed Biologics Inc. Income Statement

Last quarter (Q2 2026), TaiMed Biologics Inc.'s total revenue was NT$155.84M, an increase of 13.30% from the same quarter last year. In Q2, TaiMed Biologics Inc.'s net income was NT$-72.73M. See TaiMed Biologics Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 611.35MNT$ 610.16MNT$ 491.78MNT$ 563.01MNT$ 413.44M
NT$ 259.45MNT$ 211.22MNT$ 225.23MNT$ 215.71MNT$ 83.95M
NT$ 454.10MNT$ 463.49MNT$ 391.46MNT$ 407.57MNT$ 570.32M
Depreciation and AmortizationNT$ 152.99MNT$ 153.66MNT$ 155.39MNT$ 156.45MNT$ 156.66M
NT$ -41.66MNT$ -35.57MNT$ -24.61MNT$ -102.74MNT$ -306.83M
NT$ -194.65MNT$ -252.27MNT$ -166.23MNT$ -259.19MNT$ -463.49M
NT$ 26.87MNT$ 50.44MNT$ -28.58MNT$ -77.43MNT$ 15.43M
NT$ -167.78MNT$ -201.83MNT$ -194.81MNT$ -269.29MNT$ -470.93M
NT$ -167.78MNT$ -201.83MNT$ -194.81MNT$ -279.39MNT$ -478.38M
Per Share Metrics
Basic EPSNT$ -0.61NT$ -0.75NT$ -0.77NT$ -1.05NT$ -1.87
Diluted EPSNT$ -0.61NT$ -0.75NT$ -0.77NT$ -1.05NT$ -1.87
Weighted Average Shares Outstanding275.04M268.21M253.00M256.04M255.94M
Weighted Average Shares Outstanding (Diluted)275.04M268.21M253.00M256.04M255.94M

Currency in TWD

TaiMed Biologics Inc. Earnings and Revenue History

-800M0800M1.6B-7500 %-5000 %-2500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin